We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Webinar | Generic Drug Labeling, Product Liability, and the Changing FDA Regulatory Landscape

HL Pharmaceutical & Biotechnology Team

07 March 2014
Berkley Life Sciences, Hogan Lovells, and Bowman and Brooke would like to invite you to a 60-minute webinar on Generic Drug Labeling, Product Liability, and the Changing FDA Regulatory Landscape.

The webinar will take place Tuesday, March 11, 2014 at 2:00 p.m. ET.

To register, please click here.

Continuing education

 

Pending CLE certification:

This program is pending approval for CLE credit in New York and California. For all other jurisdictions, attendees will receive a Uniform Certificate of Attendance.

Note to NY Lawyers:

This program is appropriate for non-transitional lawyers, but not acceptable for newly admitted lawyers.

For any questions regarding this event, please contact Kristen Walker.

For the latest government regulatory developments please visit us at Focus on Regulation at www.hlregulation.com

HL Pharmaceutical & Biotechnology Team

EMA to Revise Herbal Medicines Guideline

On 1 September 2016, the European Medicines Agency ("EMA") opened for public consultation a Draft revision to its Guideline on the assessment of clinical safety and efficacy in the...

08 September 2016
Loading data